Oral chemotherapy for poor risk small-cell lung cancer patients with combined idarubicin and etoposide. [electronic resource]
Producer: 19891208Description: 937-9 p. digitalISSN:- 0250-7005
- Administration, Oral
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Small Cell -- drug therapy
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Humans
- Idarubicin -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Neoplasm Metastasis
- Neoplasm Staging
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.